Premium
Oxatomide in Seasonal Rhinoconjunctivitis
Author(s) -
Möller Christian,
Björksén Bengt
Publication year - 1980
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1980.tb01773.x
Subject(s) - antihistamine , cinnarizine , medicine , terfenadine , placebo , phenylpropanolamine , histamine h1 receptor , anesthesia , histamine h1 antagonists , dermatology , antagonist , histamine , alternative medicine , receptor , pathology
The new antiallergic drug oxatomide was evaluated in 40 schoolchildren suffering from severe allergic seasonal rhinoconjunctivitis. Antihistamine drugs had earlier given insufficient symptomatic relief. Double–blind technique was used. There was no significant difference in effect between oxatomide, the antibistamine cinnarizine in combination with phenylpropanolamine and placebo. The results do not support the hypothesis that oxatomide is superiot to antibistamine drugs in the treatment of severe seasonal rhinoconjunctivitis.